PHOX2B is a novel and specific marker for minimal residual disease testing in neuroblastoma

J Stutterheim, A (Ad) Gerritsen, L Zappeij-Kannegieter, I Kleijn, R Dee, L Hooft, MM Noesel, M Bierings, F Berthold, R Versteeg, HN Caron, CE van der Schoot, GAM Tytgat

Research output: Contribution to journalArticleAcademicpeer-review

69 Citations (Scopus)
Original languageUndefined/Unknown
Pages (from-to)5443-5449
Number of pages7
JournalJournal of Clinical Oncology
Issue number33
Publication statusPublished - 2008

Cite this